Xeris Biopharma Holdings, Inc., a commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois. It offers Gvoke, a ready-to-use liquid-stable glu...
Q2 2026
Aug 6, 2026
Q1 2026
May 7, 2026
FY 2025
Mar 2, 2026
Q4 2025
Q3 2025
Nov 6, 2025
